New 25-Valent vaccine aims to shield infants from deadly pneumococcal infections

NCT ID NCT06790290

Ongoing ⭐️ VACCINE ⭐️ Sponsor: Inventprise Inc. Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 23 times

Summary

This study tests a new vaccine (IVT PCV-25) designed to protect healthy infants against 25 types of pneumococcal bacteria, which can cause serious illnesses like pneumonia and meningitis. About 421 babies will receive either the new vaccine or an existing one at 6, 10, and 14 weeks of age. Researchers will monitor safety and measure immune responses to see if the new vaccine works as well as or better than current options.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL DISEASE, INVASIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Grand Centennial Homes Clinic

Kawit, Cavite, Philippines
Health Index Multispecialty Clinic

Bacoor, Cavite, Philippines
University of the Philippines-National Health Institute_Doña Nena Health Center

Pasay, National Capital Region, Philippines

Conditions

Explore the condition pages connected to this study.

PNEUMOCOCCAL DISEASE, INVASIVE